Baptist Health earns Center of Excellence designation for preventing the spread of drug-resistant infectious diseases

Baptist Health has been designated an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America (IDSA). The award recognizes the health system’s commitment to advancing research in antimicrobial resistance and preventing the spread of drug-resistant infectious diseases within Jacksonville and beyond. Baptist Health is one of only two health systems in North Florida to have earned the designation.

Antimicrobials such as antibiotics, antivirals, antifungals, and antiparasitics are medicines to prevent and treat infectious diseases such as E.coli, flu and pneumonia. When these medicines are no longer effective in fighting infections, antimicrobial resistance (AMR) occurs. AMR is an urgent global public health threat. Antimicrobial-resistant infections are more difficult or sometimes even impossible to treat and can often result in a patient’s need for intensive and prolonged care.

As an Antimicrobial Stewardship Center of Excellence, Baptist Health is enhancing the health and well-being of the community by promoting the responsible use of antimicrobials to prevent the development and spread of drug-resistant infections that can cause severe illnesses. Advocating for the proper use of these medicines improves safety and outcomes by ensuring patients receive the most effective treatment for their particular illness.

“We’re honored to be recognized as an Antimicrobial Stewardship Center of Excellence for our work to prevent the spread of drug-resistant infections,” said Shalika Katugaha, MD, FIDSA, FACP, medical director of Select Specialties, Infectious Disease Specialist at Baptist Health. “Antimicrobial resistance is one of the greatest global health threats. By championing the responsible use of antimicrobials, we’re helping to create a healthier community now and for future generations.”

The designation is granted to institutions that have successfully implemented antimicrobial stewardship programs led by infectious diseases-trained physicians and pharmacists. These programs integrate best practices to slow the emergence of antimicrobial resistance and optimize the treatment of infections.

The IDSA designation requires that institutions meet the high standards set by the IDSA and the Society for Healthcare Epidemiology of America (SHEA) in their evidence-based guidelines as well as guidelines set by the Centers for Disease Control and Prevention (CDC) in its Core Elements of Hospital Antibiotic Stewardship Programs. It also demonstrates Baptist Health’s commitment to meeting the antimicrobial stewardship standards set by The Joint Commission.